Literature DB >> 27508518

Host-pathogen interactions of nontypeable Haemophilus influenzae: from commensal to pathogen.

Benjamin Luke Duell1, Yu-Ching Su1, Kristian Riesbeck1.   

Abstract

Nontypeable Haemophilus influenzae (NTHi) is a commensal microbe often isolated from the upper and lower respiratory tract. This bacterial species can cause sinusitis, acute otitis media in preschool children, exacerbations in patients suffering from chronic obstructive pulmonary disease, as well as conjunctivitis and bacteremia. Since the introduction of a vaccine against H. influenzae serotype b in the 1990s, the burden of H. influenzae-related infections has been increasingly dominated by NTHi. Understanding the ability of NTHi to cause infection is currently an expanding area of study. NTHi is able to exert differential binding to the host tissue through the use of a broad range of adhesins. NTHi survival in the host is multifaceted, that is, using virulence factors involved in complement resistance, biofilm, modified immunoglobulin responses, and, finally, formation and utilization of host proteins as a secondary strategy of increasing the adhesive ability.
© 2016 Federation of European Biochemical Societies.

Entities:  

Keywords:  zzm321990Haemophiluszzm321990; adhesion; biofilm formation; extracellular matrix; intracellular; serum resistance

Mesh:

Substances:

Year:  2016        PMID: 27508518     DOI: 10.1002/1873-3468.12351

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  39 in total

1.  Discovery and Contribution of Nontypeable Haemophilus influenzae NTHI1441 to Human Respiratory Epithelial Cell Invasion.

Authors:  C P Ahearn; C Kirkham; L D Chaves; Y Kong; M M Pettigrew; T F Murphy
Journal:  Infect Immun       Date:  2019-10-18       Impact factor: 3.441

2.  Serum IgM and C-Reactive Protein Binding to Phosphorylcholine of Nontypeable Haemophilus influenzae Increases Complement-Mediated Killing.

Authors:  Jeroen D Langereis; Eva S van der Pasch; Marien I de Jonge
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

3.  Haemophilus spills its guts to make a biofilm.

Authors:  H Steven Seifert
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-26       Impact factor: 11.205

Review 4.  Insights on persistent airway infection by non-typeable Haemophilus influenzae in chronic obstructive pulmonary disease.

Authors:  Christian P Ahearn; Mary C Gallo; Timothy F Murphy
Journal:  Pathog Dis       Date:  2017-06-01       Impact factor: 3.166

5.  Transcutaneous immunization with a nontypeable Haemophilus influenzae dual adhesin-directed immunogen induces durable and boostable immunity.

Authors:  Laura A Novotny; Lauren O Bakaletz
Journal:  Vaccine       Date:  2020-01-27       Impact factor: 3.641

Review 6.  Translating Recent Microbiome Insights in Otitis Media into Probiotic Strategies.

Authors:  Marianne F L van den Broek; Ilke De Boeck; Filip Kiekens; An Boudewyns; Olivier M Vanderveken; Sarah Lebeer
Journal:  Clin Microbiol Rev       Date:  2019-07-03       Impact factor: 26.132

7.  Expression of the Nontypeable Haemophilus influenzae Type IV Pilus Is Stimulated by Coculture with Host Respiratory Tract Epithelial Cells.

Authors:  Elaine M Mokrzan; Taylor J Johnson; Lauren O Bakaletz
Journal:  Infect Immun       Date:  2019-11-18       Impact factor: 3.441

Review 8.  Bacterial-Host Interactions: Physiology and Pathophysiology of Respiratory Infection.

Authors:  A P Hakansson; C J Orihuela; D Bogaert
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

9.  Nontypeable Haemophilus influenzae Type IV Pilus Mediates Augmented Adherence to Rhinovirus-Infected Human Airway Epithelial Cells.

Authors:  Stephen L Toone; Michelle Ratkiewicz; Laura A Novotny; Binh L Phong; Lauren O Bakaletz
Journal:  Infect Immun       Date:  2020-08-19       Impact factor: 3.441

Review 10.  Host microbiota can facilitate pathogen infection.

Authors:  Emily J Stevens; Kieran A Bates; Kayla C King
Journal:  PLoS Pathog       Date:  2021-05-13       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.